Metraipolis › archive › dc_a35623fa36ba
Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41513590
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41513590
- DOI
- 10.1002/cam4.71507
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:11:03.513Z
- SHA-256 of the archived text
76116b3e4aa40cc529c8b2854a550e91d1e8b4790a0083b8ca840bf47430d6b3- Stable URL of this page
https://metraipolis.com/documento/dc_a35623fa36ba
How to cite
Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41513590 — Europe PMC (en), https://europepmc.org/article/MED/41513590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a35623fa36ba (Metraipolis archive dc_a35623fa36ba, sha256 76116b3e4aa40cc529c8b2854a550e91d1e8b4790a0083b8ca840bf47430d6b3)
BibTeX
@misc{dca35623fa36ba,
title = {Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41513590},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41513590},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a35623fa36ba; sha256 76116b3e4aa40cc529c8b2854a550e91d1e8b4790a0083b8ca840bf47430d6b3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41513590. Agents can read the archived copy with the MCP tool read_document.